Works matching IS 17568722 AND DT 2023 AND VI 16 AND IP 1
Results: 123
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01487-5
- By:
- Publication type:
- Article
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01486-6
- By:
- Publication type:
- Article
Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01489-3
- By:
- Publication type:
- Article
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01488-4
- By:
- Publication type:
- Article
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01480-y
- By:
- Publication type:
- Article
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01477-7
- By:
- Publication type:
- Article
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01485-7
- By:
- Publication type:
- Article
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01465-x
- By:
- Publication type:
- Article
BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01479-5
- By:
- Publication type:
- Article
Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01475-9
- By:
- Publication type:
- Article
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01482-w
- By:
- Publication type:
- Article
Hyperhomocysteinemia potentiates megakaryocyte differentiation and thrombopoiesis via GH-PI3K-Akt axis.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01481-x
- By:
- Publication type:
- Article
Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01471-z
- By:
- Publication type:
- Article
Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01484-8
- By:
- Publication type:
- Article
Metabolism, metabolites, and macrophages in cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01478-6
- By:
- Publication type:
- Article
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01476-8
- By:
- Publication type:
- Article
Novel target and treatment agents for natural killer/T-cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01483-9
- By:
- Publication type:
- Article
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01467-9
- By:
- Publication type:
- Article
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01474-w
- By:
- Publication type:
- Article
Clinical development of mRNA therapies against solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01457-x
- By:
- Publication type:
- Article
Advances of medical nanorobots for future cancer treatments.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01463-z
- By:
- Publication type:
- Article
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01470-0
- By:
- Publication type:
- Article
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01469-7
- By:
- Publication type:
- Article
Tumor-associated myeloid cells in cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01473-x
- By:
- Publication type:
- Article
A gene signature can predict risk of MGUS progressing to multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01472-y
- By:
- Publication type:
- Article
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01462-0
- By:
- Publication type:
- Article
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01468-8
- By:
- Publication type:
- Article
Exosomal circRNA: emerging insights into cancer progression and clinical application potential.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01452-2
- By:
- Publication type:
- Article
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01464-y
- By:
- Publication type:
- Article
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01460-2
- By:
- Publication type:
- Article
Small RNA modifications: regulatory molecules and potential applications.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01466-w
- By:
- Publication type:
- Article
A novel non-invasive exhaled breath biopsy for the diagnosis and screening of breast cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01459-9
- By:
- Publication type:
- Article
Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01455-z
- By:
- Publication type:
- Article
Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK<sup>+</sup> T-cell lymphoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01461-1
- By:
- Publication type:
- Article
Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01446-0
- By:
- Publication type:
- Article
Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01453-1
- By:
- Publication type:
- Article
Gastric cancer treatment: recent progress and future perspectives.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01451-3
- By:
- Publication type:
- Article
1-year survival in haemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003–2018.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01434-4
- By:
- Publication type:
- Article
The artificial intelligence and machine learning in lung cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01456-y
- By:
- Publication type:
- Article
Cancer cachexia: molecular mechanisms and treatment strategies.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01454-0
- By:
- Publication type:
- Article
Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01450-4
- By:
- Publication type:
- Article
Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01448-y
- By:
- Publication type:
- Article
Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01445-1
- By:
- Publication type:
- Article
Echinomycin as a promising therapeutic agent against KSHV-related malignancies.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01441-5
- By:
- Publication type:
- Article
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01443-3
- By:
- Publication type:
- Article
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01442-4
- By:
- Publication type:
- Article
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01444-2
- By:
- Publication type:
- Article